Overview
We study the effect of intravenous labetalol versus hydralazine in sever preeclampsia patients on cerebral blood flow and neurological outcome
Eligibility
Inclusion Criteria:
- patient with clinical diagnosis of sever preeclampsia
Exclusion Criteria:
Patient with history of previous intracranial lesion Patient with history of heart disease/allergy to drug Patient with history of arrhythmia/anticoagulation Any craniotemporal lesion
-